International Journal of Technology Assessment in Health Care

Article	Citations
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	117
Patient and public involvement in health technology assessment: update of a systematic review of international experiences	27
The effects of mobile apps on stress, anxiety, and depression: overview of systematic reviews	26
The broader societal impacts of COVID-19 and the growing importance of capturing these in health economic analyses	25
Health technology assessment for digital technologies that manage chronic disease: a systematic review	25
Development of a checklist to guide equity considerations in health technology assessment	21
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal	19
Environmental impact assessment in health technology assessment: principles, approaches, and challenges	15
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements	15
Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach	14
Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story	13
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements	13
An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency	13
Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI)	13
Considering and communicating uncertainty in health technology assessment	13
Early economic evaluation to guide the development of a spectroscopic liquid biopsy for the detection of brain cancer	13
Mind the evidence gap: the use of patient-based evidence to create “complete HTA” in the twenty-first century	13
Economic evaluation guidelines in low- and middle-income countries: a systematic review	12
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic	12
Systematic review search methods evaluated using the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses and the Risk Of Bias In Systematic reviews tool	11
Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration	10
Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices	10
A review of HTA guidelines on societal and novel value elements	10
Evaluation of the impact of patient input in health technology assessments at NICE	10
Incorporating environmental and sustainability considerations into health technology assessment and clinical and public health guidelines: a scoping review	10

COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection	10
Examining the impact of different country processes for appraising rare disease treatments: a case study analysis	10
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force	10
PP424 Piloting A Comprehensive Search For eHealth Definitions In The Grey Literature: Preliminary Results From A Systematic Scoping Review	9
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation	9
How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations	9
A model-based study to estimate the health and economic impact of health technology assessment in Thailand	9
Economic impact of the use of the National Surgical Quality Improvement Program	9
Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment	8
Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries	8
Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations	8
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework	7
Application of a health technology assessment framework to digital health technologies that manage chronic disease: a systematic review	7
Implementation of a new Digi-HTA process for digital health technologies in Finland	7
On the role of cost-effectiveness thresholds in healthcare priority setting	7
Peer review of searches for studies for health technology assessments, systematic reviews, and other evidence syntheses	7
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	7
Addressing uncertainty in relative effectiveness assessments by HTA organizations	7
Health Technology Assessment in Support of National Health Insurance in South Africa	7
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis	7
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?	7
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	7
Developing recommendations for the diagnosis and treatment of Lyme disease: the role of the patient's perspective in a controversial environment	7
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group	6
A framework for action to improve patient and public involvement in health technology assessment	6
Stakeholder preferences for attributes of digital health technologies to consider in health service funding	6
Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe	6
Evaluating physicians’ perspectives on the efficiency and effectiveness of the electronic prescribing system	6
Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease	6
A toolkit of methods of development-focused health technology assessment	6
Relevance of the newly defined Health Technology Assessment: COVID-19 and beyond	5
Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision making	5
Qualitative comparative analysis of health economic evaluation guidelines for health technology assessment in European countries	5
Health technology assessment applied to emergency preparedness: a new perspective	5
Prioritizing critical-care resources in response to COVID-19: lessons from the development of Thailand's Triage protocol	5
Patient and public involvement in Health Technology Assessment: a new dawn?	5
Technology assessment framework for precision health applications	5
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities	4
Lessons from the vaginal mesh scandal: enhancing the patient-centric approach to informed consent for medical device implantation	4
Health technology assessment: A matter of facts and values	4
Economic evaluation of genomic/genetic tests: a review and future directions	4
Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature	4
Access to medicines in Turkey: Evaluation of the process of medicines brought from abroad	4
Postlaunch evidence generation practices among health technology assessment bodies in Europe	4
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of “Failed” R&D Efforts	4
Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review	4
Topic selection process in health technology assessment agencies around the world: a systematic review	4
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks	4
Establishment and implementation of hospital-based health technology assessment at King Hussein Cancer Center: can our model be an example?	4
Development of an international template to support patient submissions in Health Technology Assessments	4

Cost-effectiveness analysis of magnetic resonance-guided focused ultrasound ablation for palliation of refractory painful bone metastases	4
Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review	4
A review of implementation frameworks to operationalize health technology assessment recommendations for medical technologies in the Singapore setting	4
Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot	4
Evaluating traditional and complementary medicines: Where do we go from here?	4
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”	4
Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health	4
Telemedicine and the assessment of clinician time: a scoping review	3
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases	3
Systems thinking in health technology assessment: a scoping review	3
A model to assess the impact of digital technologies on the health-related quality of life	3
Overview of information retrieval in a hospital-based health technology assessment center in a Swedish region	3
Evidence-based searching for health technology assessment: keeping up to date with SuRe Info	3
Strengthening patient outcome evidence in health technology assessment: a coproduction approach	3
Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3	3
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	3
Understanding innovation of health technology assessment methods: the IHTAM framework	3
Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future	3
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment	3
Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project	3
Involvement of information specialists and statisticians in systematic reviews	3
Core competencies for ethics experts in health technology assessment	3
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling	3
Disinvestment in healthcare: a scoping review of systematic reviews	3
Disruptive technologies in health care disenchanted: a systematic review of concepts and examples	3
Pilot approach to analyzing patient and citizen involvement in health technology assessment in four diverse low- and middle-income countries	3
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework – Corrigendum	3
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies	3
Test–retest reliability of the Cost for Patients Questionnaire	3
Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications	3
The development process of economic evaluation guidelines in low- and middle-income countries: a systematic review	3
Development of a decisional flowchart for meaningful patient involvement in Health Technology Assessment	3
Redefining Health Technology Assessment: A Comment on “The New Definition of Health Technology Assessment: A Milestone in International Collaboration”	3
A framework for local-level economic evaluation to inform implementation decisions: health service interventions to prevent hospital-acquired hypoglycemia	3
Creating enriched training sets of eligible studies for large systematic reviews: the utility of PubMed's Best Match algorithm	3
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis	3
Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review	3
Patient and caregiver engagement in the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System (HCHSS) process	2
The role of ethical analysis in conducting a health technology assessment of medical treatments for gender dysphoria	2
PP138 Current Status Of Healthcare Decision Making And Future Perspective Of The Health Technology Assessment Implementation Roadmap In Turkey	2
Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets	2
PP40 Health Apps To Manage Depression: Can We Separate The Grain From The Chaff? EvalDepApps Project	2
The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries’ past health technology assessments	2
A HTA of what? Reframing through including patient perspectives in health technology assessment processes	2
Best practice considerations on the assessment of robotic assisted surgical systems: results from an international consensus expert panel	2
Design of a multiple criteria decision analysis framework for prioritizing high-impact health technologies in a regional health service	2
A decision-support tool for funding health innovations at a tertiary academic medical center	2
Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews	2
Demonstrating the influence of HTA: INAHTA member stories of HTA impact	2
European collaboration on health technology assessment: looking backward and forward	2
Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body	2
Do France, Germany, and Italy agree on the added therapeutic value of medicines?	2
EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness	2
The cost of metastatic prostate cancer using time-driven activity-based costing	2
Hospital-based health technology assessment in Brazil: current experiences and challenges	2
Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System: the cefiderocol example	2
Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults	2
Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach	2
PD20 Real-World Evidence To Support Single Arm Trials Of Oncology Interventions: Necessity or ‘NICE’ (National Institute for Health and Care Excellence) to Have?	2
Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis	2
Moving from intervention management to disease management: a qualitative study exploring a systems approach to health technology assessment in Canada	2
A different animal but the same beast? Using development-focused health technology assessment to define the value proposition of medical technologies	2
The contribution of French patient and consumer groups to health technology assessments over a 2-year period: an observational retrospective study	2
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	2
PP162 Digital Medication Health Service Platforms Of Pharmaceutical Companies As Novel Sources Of Real-World Data For Health Technology Assessment	2
Glycated hemoglobin as a surrogate for evaluating the effectiveness of drugs in diabetes mellitus trials: a systematic review and trial-level meta-analysis	2
Cost-effectiveness of neuromuscular electrical stimulation for the treatment of mild obstructive sleep apnea: an exploratory analysis	2
Manufacturers’ perceptions of the decision-making process for new drug reimbursement in South Korea	2
Patient and citizen participation at the organizational level in health technology assessment: an exploratory study in five jurisdictions	2
Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America	2
Expanding health technology assessment towards broader value: Ireland as a case study	2
Early access schemes for innovative health technologies: the views of international stakeholders	2
Survey investigating the knowledge and awareness of payers and patient advocacy groups about the health technology assessment process in Lebanon	2
Adherence to country-specific guidelines among economic evaluations undertaken in three high-income and middle-income countries: a systematic review	2
Promoting health economic evaluation studies in the AYUSH system of medicine: the need of the hour	2
Exploring facilitators and barriers to introducing health technology assessment: a systematic review	2
PD45 Paying For Digital Health: What Evidence Is Needed?	2
PP90 Effectiveness Of Music Therapy For Autism Spectrum Disorder, Dementia, Depression, Insomnia, And Schizophrenia	1
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	1
Using early health economic modeling to inform medical innovation development: a soft robotic sock in poststroke patients in Singapore	1

THE EXTENT AND QUALITY OF QUALITATIVE EVIDENCE INCLUDED IN HEALTH TECHNOLOGY ASSESSMENTS: A REVIEW OF SUBMISSIONS TO NICE AND CADTH	1
EUnetHTA’s contribution to the new legal framework for health technology assessment cooperation in Europe	1
OP223 A Semi-Automated Process To Monitor The Clinical Development And Regulatory Approval Pathway Of Innovative Medicines	1
Clinical effectiveness reporting of novel cancer drugs in the context of non-proportional hazards: a review of nice single technology appraisals	1
Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia	1
Synthesizing quantitative and qualitative information on multiple comparisons of health interventions to facilitate knowledge transfer: an example from an EUnetHTA multi-HTA	1
Patients’ knowledge and awareness about patient support programs: a cross-sectional study on Lebanese adults with chronic diseases	1
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect	1
OP28 Health Technology Assessment: A Situation Analysis Of Zimbabwe	1
Opportunities to improve reporting of rapid response in health technology assessment	1
Telemedicine experience between two hospitals from Angola and Spain	1
PP531 Quality Of Life Of Patients With Long-Chain Fatty Acid Oxidation Disorders Before And During Treatment With Triheptanoin	1
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations	1
Emerging healthcare interventions: Patient-Centered Outcomes Research Institute’s programmatic initiative	1
PP28 Is My Medicine Suitable For An Outcomes Based Agreement? The Feasibility Conundrum	1
Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets	1
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives	1
OP95 A Systematic Review Of The Cost And Cost Effectiveness Of Immunoglobulin Treatment In Patients With Hematological Malignancies	1
Response to redefining health technology assessment: a comment on “the new definition of health technology assessment: a milestone in international collaboration”	1
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France	1
PP261 Development Of A Mapping Algorithm To Predict SF-6D Values In People With Drug-Resistant Focal Onset Seizures	1
OP535 Cost-Effectiveness Of Internet-Based HIV Screening In Men Who Have Sex With Men in Vancouver, British Columbia, Canada	1
Patient Perspectives: An Integral Part of Health Technology Assessment Methodology	1
Deliberative processes in health technology assessment of medicines: the case of Spain	1
Novel approach to decision making for orphan drugs	1
Using social media research in health technology assessment: stakeholder perspectives and scoping review	1
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool	1
PP445 Mapping The Trend Of The Da Vinci Surgical System Use In China	1
OP283 A Pipeline Analysis Of Advanced Therapy Medicinal Products (ATMPs) In Late-Stage Clinical Development	1
Adjustment of publication bias using a cumulative meta-analytic framework	1
Genuine policy learning is fundamental: the journey of the United Arab Emirates toward the establishment of health technology assessment	1
Acceptability of Manufacturer-Proposed Utility Values for NICE Cancer Medicine Appraisals: Analysis of Manufacturers’ Information Sources	1
Assessing the early impact of a hospital-based health technology assessment program, smart innovation	1
PP70 Enhancing HTA Processes In The Maltese System For Introducing New Medicines	1
An evaluation of managed access agreements in England based on stakeholder experience	1
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders	1
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective	1
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis	1
Beyond clinical and cost-effectiveness: The contribution of qualitative research to health technology assessment	1
Assessing progression of health technology assessment implementation in Asia: a balanced scorecard for cross comparison of selected countries in Asia	1
The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum	1
OP01 Convergent Validity Between Discrete Choice Experiment And Other Stated Preference Methods: A Multistudy Comparison	1
Economic feasibility of a novel tool to assist extubation decision-making: an early health economic modeling	1
A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value	1
Mapping horizon scanning systems for medical devices: similarities, differences, and lessons learned	1
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement	1
PP43 Impact Of The COVID-19 Pandemic In The Brazilian National Committee for Health Technology Incorporation (Conitec) Recommendation Process	1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	1
PP414 Improving The Accessibility Of Scottish Medicines Consortium Advice	1
Informing decision makers about public preferences for different modalities of cancer treatment in the Rhône–Alps region in France	1
A Technical Review of the ISPOR Presentations Database Identified Issues in the Search Interface and Areas for Future Development	1
Response to “UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP”	1
OP152 Use of Real-world Evidence By The Brazilian Health Technology Assessment Committee (Conitec) For Monitoring Of Health Technologies	1
PP385 Using Common Data Models And Data Networks For Evidence Generation In Health Technology Assessment	1
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	1
Cost-utility of a web-based intervention to promote maternal mental health among postpartum women presenting low risk for postpartum depression	1
OP196 Clinical Decision Support Systems (CDSS) For Antibiotic Management: Factors Limiting Sustainable Digital Transformation	1
PP434 Quality Of Studies Submitted To Support Requests For Medical Devices And Equipment Incorporation In A Teaching Hospital	1
Neglected impacts of patient decision-making associated with genetic testing	1
A voice to be heard: patient and public involvement in health technology assessment and clinical practice guidelines in Malaysia	1
PP228 Strategy For Including Information On The Research Priorities Of Patients And Experts In Health Technology Assessment Reports	1
Toward a broader concept of societal value: family spillovers in Alzheimer's disease	1
PD26 Overscreening For Older Women In Cervical And Breast Cancer Screening In Japan	1
PP290 Ongoing Swedish Initiatives To Improve The Potential For Real World Data Assessment Of Medical Devices	1
Methods and criteria for the assessment of orphan drugs: a scoping review	1
Closing the loop between horizon scanning and health technology assessment – an overview of topics submitted for appraisal in England	1
PP265 Application Of A Case-Mix Method For Medical Consumables Management In Anhui Province, China Using Healthcare Big Data	1
PP140 Barriers And Prospects For The Development Of Hospital-Based Health Technology Assessment In Kazakhstan	1
Using INTEGRATE-HTA for the assessment of videorasterstereography in idiopathic scoliosis	1
OP51 Improving Childhood Cancer Management And Financing In Ghana: Results From Stakeholder Mapping and Analysis	1
Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America	1
Introduction of hospital-based health technology assessment in China: experiences from seven pilot hospitals	1
The added value of applying a disinvestment approach to the process of health technology assessment in Italy	1
OP520 Evaluating Long-Term Survival From Clinical Trials: Does Real-World Evidence Change the Paradigm?	1
Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan	1
OP87 Value From A Multi-stakeholder Perspective: A Framework To Assess Digital Health Solutions For Improving Chronic Disease Management	1
PP553 Study On The Utilization Of Medical Resources In Patients With Malignant Tumors in China	1
PP299 A Framework And Analysis Assessing The Impact Of Patient-Centered Outcome Evidence In HTA Appraisals	0
PP231 Safety, Effectiveness And Economic Analysis Of Exercise Intervention For Prevention Of Cognitive And Functional Deterioration In Hospitalized Patients	0
PP230 Safety, Effectiveness, And Cost Effectiveness Of Interventions For Preventing Delirium In Hospitalized Patients	0
PP428 Rechargeable Versus Recharge-Free Sacral Neurostimulation: An Australian Health Economics Analysis	0
PP262 PapSEEK: Liquid Biopsy For Endometrial And Ovarian Cancer Screening	0
A collaborative pilot on current awareness alerts for disinvestment and horizon scanning	0
PP94 Pandemic Preparedness: EUnetHTA COVID-19 Rapid Response With “Rolling Collaborative Reviews (RCR)”	0
PP447 Informing The Development And Evaluation Of An Evidence-Based Service Delivery Model For Mental Health Patients With Complex Needs	0
PP451 Does NICE Reimburse Oncology Treatments Meeting End-Of-Life Criteria More Often Than Treatments That Do Not?	0
PP254 Double-Counting In Evidence Synthesis Including Routinely Collected Data: Methodological and Practical Considerations	0
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance	0
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders – Erratum	0
OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder	0
PP403 New Medical Technology Adoption In Asia Pacific: Focused On South Korea And Japan	0
PP89 The Investigation And Development Of A National Formulary Monitoring System Across Wales	0
PP296 Patient Involvement In An Assessment Of The Management Of Sudden Onset Severe Headache Presenting To The Emergency Department	0
OP615 Implementing EUnetHTA Products: The Implementation Experiences In Italy	0
OP366 Characterizing The Population At Risk Of Chronic Obstructive Pulmonary Disease In China Using A Real-World Population Survey	0